STROBER, B.; PAPP, K. A.; FLACK, M.; GU, Y.; THOMPSON, E. H.; VALDECANTOS, W. C. Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s10, 2017. DOI: 10.25251/skin.1.supp.9. Disponível em: https://www.jofskin.org/index.php/skin/article/view/78. Acesso em: 1 jul. 2022.